IDF welcomes Boehringer Ingelheim as a new partner

06 July 2023

The International Diabetes Federation (IDF) is delighted to welcome Boehringer Ingelheim as a new partner to support the activities of the Federation to improve the lives of people with diabetes and prevent diabetes in those at risk.

The partnership will specifically include support of a new interactive online course on diabetes and heart health in the IDF School of Diabetes Understanding Diabetes platform, expanding IDF’s offer of educational resources for people with diabetes, their caregivers and people at risk.

Founded in 1885 and family-owned ever since, Boehringer Ingelheim is a leading research-driven biopharmaceutical company that creates value through innovation in areas of high unmet medical need across three business areas – Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Keep up to date with all the work we’re doing